AUTOCRYPT Achieves WebTrust Accreditation for V2X PKI Infrastructure
WD Advances Next-Generation Trusted Infrastructure with Industry's First Post-Quantum Cryptography Hard Drives to Help Secure the Future of AI Data
Parkland (TSE:PKI) Stock Passes Above 200 Day Moving Average – Here’s What Happened
New Research Shows That Legacy PKI Puts Digital Identities at Risk, With 56% of Organizations Experiencing Services Disruption
Parkland (TSE:PKI) Stock Price Passes Above Two Hundred Day Moving Average – Here’s What Happened
Parkland (TSE:PKI) Stock Price Crosses Above 200-Day Moving Average – Time to Sell?
Parkland (TSE:PKI) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
Parkland Corporation anuncia la finalización de la adquisición por Sunoco LP
Keyfactor Unlocks Digital Trust with Integrations for Advanced PKI & Certificate Automation in ServiceNow
Real World Evidence (RWE) Oncology Market to Reach $3.51 Billion by 2035, Growing at a CAGR of 14.7% from 2025--Exclusive Report by Meticulous Research®
PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry
WISeKey PKI and SEALSQ Post-Quantum Technologies Enhance E-Voting Security through Advanced Cybersecurity and AI Integration
Climb Channel Solutions Announces Keyfactor as New North American Channel Partner
PARKLAND ANNOUNCES PRICING OF SENIOR UNSECURED NOTES OFFERING
PARKLAND ANNOUNCES US$500 MILLION OFFERING OF SENIOR UNSECURED NOTES
AppViewX Recognized by Outstanding Security Performance Awards 2024
PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform
Parkland appoints Nora Duke to its Board of Directors
PerkinElmer (PKI) Q1 Earnings Surpass Estimates
Revvity Announces Financial Results for the First Quarter of 2023
Is a Surprise Coming for Revvity (PKI) This Earnings Season?
Revvity (PKI) to Report Q1 Earnings: Is a Beat in the Cards?
Will PerkinElmer (PKI) Beat Estimates Again in Its Next Earnings Report?
PerkinElmer Board Declares Quarterly Dividend
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
Dirk Bontridder Appointed as CEO of New PerkinElmer Business Acquired by New Mountain Capital
PerkinElmer (PKI) Completes Divestment, New Business Name in Q2
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
PerkinElmer's (PKI) Latest Launch to Boost Research Workflows
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
PerkinElmer's (PKI) Q4 Earnings Top, Revenues Decline Y/Y
PerkinElmer, Inc. (PKI) Q4 2022 Earnings Call Transcript
PerkinElmer (PKI) Beats Q4 Earnings and Revenue Estimates
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate
Adolore Biotherapeutics Strengthens Management Team and Board of Directors with the Appointments of Roelof Rongen, MSE, MBA and Mark C. Rogers, MD, MBA
Prahlad Singh Appointed to Board of Directors of Amphenol Corporation
PerkinElmer, Inc. (PKI) 41st Annual J.P. Morgan Healthcare Conference (Transcript)
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
3 Instruments Stocks to Watch From a Challenging Industry
Why Is PerkinElmer (PKI) Up 10.3% Since Last Earnings Report?
PerkinElmer's (PKI) New Viral Vector Assays to Boost Workflows
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
PerkinElmer's (PKI) New Marketing Approval to Aid Infant Health
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
PerkinElmer to Present at 2022 Stifel Healthcare Conference
PerkinElmer (PKI) Q3 Earnings Top, Revenues Decline Y/Y